Detalhe da pesquisa
1.
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Ann Oncol
; 33(4): 426-433, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35074424
2.
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
Ann Oncol
; 33(12): 1284-1295, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36089134
3.
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
Ann Oncol
; 32(3): 337-350, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33455880
4.
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients.
Ann Oncol
; 31(8): 991-1000, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32348852
5.
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas.
Ann Oncol
; 31(5): 599-608, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32178965
6.
Identifying patients with NTRK fusion cancer.
Ann Oncol
; 30(Suppl_8): viii16-viii22, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31738428
7.
Identifying patients with NTRK fusion cancer.
Ann Oncol
; 30 Suppl 8: viii16-viii22, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32223934
8.
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
Ann Oncol
; 30(9): 1417-1427, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31268127
9.
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
Ann Oncol
; 30(8): 1221-1231, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31050713
10.
Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.
Ann Oncol
; 30(4): 597-603, 2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30891595
11.
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer.
Ann Oncol
; 30(8): 1311-1320, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31086949
12.
Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.
Ann Oncol
; 28(12): 3015-3021, 2017 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29045506
13.
Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers.
Ann Oncol
; 27(7): 1286-91, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27056998
14.
Erratum to 'Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group': [Annals of Oncology 30 (2019) 1221-1231].
Ann Oncol
; 32(8): 1069-1071, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34090768
15.
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
Ann Oncol
; 27(5): 920-6, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26884591
16.
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.
Cancer
; 121(18): 3212-3220, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26096453
17.
18.
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing.
Ann Oncol
; 25(2): 423-8, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24478319
19.
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
Nat Genet
; 17(3): 309-13, 1997 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-9354795
20.
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.
Eur Respir J
; 39(2): 366-72, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21778168